[
  {
    "protocolId": 8473,
    "uploadDate": "new Date('09/04/2016')",
    "protocolName": "Sample-Prot",
    "sponsor": "Eli Lilly",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "fileName": "Sample-Prot",
    "filePath": "https://www.w3.org/WAI/ER/tests/xhtml/testfiles/resources/pdf/dummy.pdf",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8474,
    "uploadDate": "new Date('09/06/2016')",
    "protocolName": "Test-Prot",
    "sponsor": "Biogen",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "fileName": "Sample-Prot-document",
    "filePath": "/Boilerplate.docx",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8475,
    "uploadDate": "new Date('09/07/2016')",
    "protocolName": "Sample-Protocol",
    "sponsor": "Biogen",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8476,
    "uploadDate": "new Date('09/08/2016')",
    "protocolName": "Example-text-test-0123456789",
    "sponsor": "Amgen",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8477,
    "uploadDate": "new Date('09/09/2016')",
    "protocolName": "Sample-Prot",
    "sponsor": "Jansen",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8478,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8479,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8480,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8481,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8482,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8483,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8484,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocolId": 8485,
    "uploadDate": "new Date('09/10/2016')",
    "protocolName": "Demo-Prot",
    "sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "indication": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  }
]
